Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alvina A. Acquaye-Mallory"'
Autor:
Amanda L. King, Alvina A. Acquaye-Mallory, Elizabeth Vera, Tito Mendoza, Jennifer Reyes, Macy L. Stockdill, Mark R. Gilbert, Terri S. Armstrong
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Primary brain tumor (PBT) patients experience higher levels of distress and anxiety than other solid tumor patients, particularly at the time of clinical evaluation when uncertainty about disease status is high (“scanxiety”).
Externí odkaz:
https://doaj.org/article/bbf381db329b4115b5ea6783adc0a7cb
Autor:
Amanda L. King, Kayla N. Roche, Heather E. Leeper, Elizabeth Vera, Tito Mendoza, Kelly Mentges, Alvina A. Acquaye-Mallory, Kendra A. Adegbesan, Lisa Boris, Eric Burton, Anna Choi, Ewa Grajkowska, Tricia Kunst, Jason Levine, Nicole Lollo, Hope Miller, Marissa Panzer, Marta Penas-Prado, Valentina Pillai, Lily Polskin, Jennifer Reyes, Solmaz Sahebjam, Macy L. Stockdill, Brett J. Theeler, Jing Wu, Mark R. Gilbert, Terri S. Armstrong
Purpose Cancer patients experience distress and anxiety when undergoing imaging studies to monitor disease status, yet these symptoms are not always appropriately identified or well-managed. This interim analysis of a phase 2 clinical trial explored
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb4dde03119b65c82057013c14e2564f
https://doi.org/10.21203/rs.3.rs-2522094/v1
https://doi.org/10.21203/rs.3.rs-2522094/v1
Autor:
Acquaye-Mallory A; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Vera E; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Choi A; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Wall K; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Aug; Vol. 13 (15), pp. e70017.
Autor:
Pascoe MM; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Wollet AR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., De La Cruz Minyety J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Vera E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Miller H; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Celiku O; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Leeper H; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Fernandez K; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland., Reyes J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Young D Jr; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Acquaye-Mallory A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Adegbesan K; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Boris L; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland., Burton E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Chambers CP; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland., Choi A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Grajkowska E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Kunst T; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland., Levine J; Center for Cancer Research Office of Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Panzer M; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland., Penas-Prado M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Pillai V; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland., Polskin L; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland., Wu J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Mendoza T; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., King AL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Shuboni-Mulligan D; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland., Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Publikováno v:
Neuro-oncology practice [Neurooncol Pract] 2024 May 24; Vol. 11 (5), pp. 640-651. Date of Electronic Publication: 2024 May 24 (Print Publication: 2024).
Autor:
Youssef G; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Acquaye-Mallory A; Neuro-Oncology Branch, Center for Cancer Research, The National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Vera E; Neuro-Oncology Branch, Center for Cancer Research, The National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Chheda MG; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA., Dunn GP; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Moliterno J; Yale School of Medicine, Chenevert Family Brain Tumor Center, Yale Cancer Center and Smilow Cancer Hospital, New Haven, Connecticut, USA., O'Brien BJ; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Venere M; Department of Radiation Oncology, James Cancer Hospital and Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, Ohio, USA.; Tzagournis Medical Research Facility, Columbus, Ohio, USA., Yust-Katz S; Neuro-Oncology Unit, Davidoff Cancer Center at Rabin Medical Center and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, The National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Publikováno v:
Neuro-oncology practice [Neurooncol Pract] 2024 Mar 13; Vol. 11 (4), pp. 494-506. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).